3 Review(s)

TLC is to identify the unknown or to confirm the identity of the analyte. It can serve as a screening step followed by HPLC confirmation and quantitation resulting in lower analytical time and cost. The revised text describes procedures for separation detection and identification of each component in 1.72 divergent• multi-component pharmaceutical formulations using both normal and R.P. layers. Most of the formulations contain several alternate mobile phases for analysts to choose from and to optimise. The revised edition contains a comprehensive chapter on detection! Visualization reagents commonly used for post-chromatographic derivatization. Each reagent contains a list of common drugs which can be detected with the reagent. About the Author Dr. P.D. Sethi received his B.Pharma. and M.Pharma from Punjab University Chandigarh and Ph.D. from University of Madras. Dr. Sethi has been associated with prestigious Federal Drugs Testing Laboratories and is pursuing his career as Pharmaceutical Analyst since last 25 years. He is associated with National Accreditation Board (NABL) Department of Science & Technology Govt. of India as an Evaluator. He is author of several monographs in the field of Pharmaceutical Analysis. Dilip Charegaonkar did his postgraduation in analytical chemistry from University of Bombay in 1974. After working with R & 0 division of Themis Pharmaceutical Research Centre for few years in 1978 he set up his own organisation Anchrom Enterprises (I) Pvt. Ltd. exclusively dedicated to TLCI HPTLC technique. Anchrom Analytical Research Laboratory with which Mr. Dilip is actively associated is engaged in development and validation of analytical methods using HPTLC. The laboratory in collaboration with Camag Switzerland regularly provides training to analysts students and academicians in HPTLC technique and its applications.